March 17, 2023
BEIJING, March 17, 2023 /PRNewswire/ -- According the latest data released at the Clinical Trials Implied Approval section on the website of China's Center for Drug Evaluation (CDE) of the National Medical Products…
Learn more
14 articles
On September 2, Likang Life Sciences and JD Health formally entered into a strategic partnership. Dr. Li Chen, Founder and CEO of Likang Life Sciences…
"Adoptive cell therapy for cancer treatment Market: Global Industry Analysis and Opportunity Assessment 2017-2027"
Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship…
A protein called FGL1 is a major inhibitory signal that blocks the immune system from fighting certain cancers, a team led by researchers at Yale Cancer…
The efficacy and safety observed with the CAR T-cell product bb21217 could help physicians get patients with heavily pretreated relapsed/refractory…
A pivotal Phase 3 clinical trial testing a combination of Cabometyx (cabozantinib) with Tecentriq (atezolizumab) versus standard care of Nevaxar…